Affiliations
AffiliationsItem in Clipboard
Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and DeathMichal F Kaminski et al. Gastroenterology. 2017 Jul.
. 2017 Jul;153(1):98-105. doi: 10.1053/j.gastro.2017.04.006. Epub 2017 Apr 17. Authors Michal F Kaminski 1 , Paulina Wieszczy 2 , Maciej Rupinski 3 , Urszula Wojciechowska 4 , Joanna Didkowska 5 , Ewa Kraszewska 6 , Jaroslaw Kobiela 7 , Robert Franczyk 3 , Maria Rupinska 3 , Bartlomiej Kocot 6 , Anna Chaber-Ciopinska 3 , Jacek Pachlewski 8 , Marcin Polkowski 3 , Jaroslaw Regula 3 AffiliationsItem in Clipboard
AbstractBackground & aims: The quality of endoscopists' colonoscopy performance is measured by adenoma detection rate (ADR). Although ADR is associated inversely with interval colorectal cancer and colorectal cancer death, the effects of an increasing ADR have not been shown. We investigated whether increasing ADRs from individual endoscopists is associated with reduced risks of interval colorectal cancer and subsequent death.
Methods: We performed a prospective cohort study of individuals who underwent a screening colonoscopy within the National Colorectal Cancer Screening Program in Poland, from January 1, 2004, through December 31, 2008. We collected data from 146,860 colonoscopies performed by 294 endoscopists, with each endoscopist having participated at least twice in annual editions of primary colonoscopy screening. We used annual feedback and quality benchmark indicators to improve colonoscopy performance. We used ADR quintiles in the whole data set to categorize the annual ADRs for each endoscopist. An increased ADR was defined as an increase by at least 1 quintile category, or the maintenance of the highest category in subsequent screening years. Multivariate frailty models were used to evaluate the effects of increased ADR on the risk of interval colorectal cancer and death.
Results: Throughout the enrollment period, 219 endoscopists (74.5%) increased their annual ADR category. During 895,916 person-years of follow-up evaluation through the National Cancer Registry, we identified 168 interval colorectal cancers and 44 interval cancer deaths. An increased ADR was associated with an adjusted hazard ratio for interval colorectal cancer of 0.63 (95% confidence interval [CI], 0.45-0.88; P = .006), and for cancer death of 0.50 (95% CI, 0.27-0.95; P = .035). Compared with no increase in ADR, reaching or maintaining the highest quintile ADR category (such as an ADR > 24.56%) decreased the adjusted hazard ratios for interval colorectal cancer to 0.27 (95% CI, 0.12-0.63; P = .003), and 0.18 (95% CI, 0.06-0.56; P = .003), respectively.
Conclusions: In a prospective study of individuals who underwent screening colonoscopy within a National Colorectal Cancer Screening Program, we associated increased ADR with a reduced risk of interval colorectal cancer and death.
Keywords: Colon Cancer; Early Detection; Efficacy; Tumor.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articlesvan Toledo DEFWM, IJspeert JEG, Bossuyt PMM, Bleijenberg AGC, van Leerdam ME, van der Vlugt M, Lansdorp-Vogelaar I, Spaander MCW, Dekker E. van Toledo DEFWM, et al. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):747-754. doi: 10.1016/S2468-1253(22)00090-5. Epub 2022 May 9. Lancet Gastroenterol Hepatol. 2022. PMID: 35550250
Hilsden RJ, Bridges R, Dube C, McGregor SE, Naugler C, Rose SM, Rostom A, Heitman SJ. Hilsden RJ, et al. Am J Gastroenterol. 2016 Dec;111(12):1743-1749. doi: 10.1038/ajg.2016.449. Epub 2016 Oct 11. Am J Gastroenterol. 2016. PMID: 27725649
Anderson JC, Butterly LF, Weiss JE, Robinson CM. Anderson JC, et al. Gastrointest Endosc. 2017 Jun;85(6):1188-1194. doi: 10.1016/j.gie.2017.01.020. Epub 2017 Jan 31. Gastrointest Endosc. 2017. PMID: 28153571 Free PMC article.
Wieszczy P, Regula J, Kaminski MF. Wieszczy P, et al. Best Pract Res Clin Gastroenterol. 2017 Aug;31(4):441-446. doi: 10.1016/j.bpg.2017.07.002. Epub 2017 Jul 6. Best Pract Res Clin Gastroenterol. 2017. PMID: 28842054 Review.
Chaptini L, Laine L. Chaptini L, et al. J Clin Gastroenterol. 2015 Apr;49(4):270-81. doi: 10.1097/MCG.0000000000000293. J Clin Gastroenterol. 2015. PMID: 25647725 Review.
Ow TW, Sukocheva OA, Tran V, Lin R, Lee SZ, Chu M, Angelica B, Rayner CK, Tse E, Iyngkaran G, Bampton PA. Ow TW, et al. World J Gastrointest Endosc. 2022 Nov 16;14(11):672-683. doi: 10.4253/wjge.v14.i11.672. World J Gastrointest Endosc. 2022. PMID: 36438878 Free PMC article.
Zhang HL, Zhang AH, Miao JH, Sun H, Yan GL, Wu FF, Wang XJ. Zhang HL, et al. RSC Adv. 2019 Jan 23;9(6):3072-3080. doi: 10.1039/c8ra08520j. eCollection 2019 Jan 22. RSC Adv. 2019. PMID: 35518968 Free PMC article. Review.
Zhang X, Li X, He Y, Law PJ, Farrington SM, Campbell H, Tomlinson IPM, Houlston RS, Dunlop MG, Timofeeva M, Theodoratou E. Zhang X, et al. Br J Cancer. 2022 Mar;126(5):822-830. doi: 10.1038/s41416-021-01655-9. Epub 2021 Dec 15. Br J Cancer. 2022. PMID: 34912076 Free PMC article.
Leung JW, Yen AW, Jia H, Opada C, Melnik A, Atkins J, Feller C, Wilson MD, Leung FW. Leung JW, et al. United European Gastroenterol J. 2019 May;7(4):477-487. doi: 10.1177/2050640619832196. Epub 2019 Feb 19. United European Gastroenterol J. 2019. PMID: 31065365 Free PMC article. Clinical Trial.
Ertem FU, Ladabaum U, Mehrotra A, Tehranian S, Shi Z, Saul M, Morris M, Crockett SD, Schoen RE. Ertem FU, et al. Gastrointest Endosc. 2018 Oct;88(4):705-711.e1. doi: 10.1016/j.gie.2018.05.012. Epub 2018 May 24. Gastrointest Endosc. 2018. PMID: 29803767 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3